11:48am ET
Investing
Just How Safe Is Abbott Labs Stock’s Dividend?
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Companies
/Healthcare
Johnson & Johnson
$270.18
▼ $5.06 (−1.84%) today
Markets open · 2:23pm ET
JNJ Coverage
Page 35
11:10am ET
Investing
6 Unstoppable Dividend Stocks To Buy If There Is a Market Crash
Everything is starting to look rosy again. The inflation data for November came in below the estimates, earnings have been reasonably good for the third quarter, and investors just celebrated a substantial…
10:26am ET
Investing
6 Reasons to Avoid Johnson & Johnson (JNJ) At All Costs
The Johnson brothers started Johnson & Johnson in 1886 JHVEPhoto / iStock Editorial via Getty Images The iconic healthcare giant was started by Robert, James, and Edward Johnson in 1886 after they…
9:30am ET
Investing
5 Dividend Aristocrats Stocks Have Raised Their Dividends For Over 60 Years
With November here, many investors are looking toward Thanksgiving, the holidays, and the end of the year. The stock market went through some of the biggest combined net selling from August to…
1:31pm ET
Investing
Warren Buffett Owns Millions of Shares of These 3 High Yielding Dividend Aristocrats
If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years the “Oracle of Omaha” has had a rock star-like presence in the investing world,…
11:03am ET
Investing
A Full Schedule of Earnings Due Tuesday Morning: Albertsons, Bank of America, Goldman Sachs, Johnson & Johnson, Lockheed Martin
Before U.S. markets open on Tuesday, these five companies are scheduled to report their quarterly earnings.
8:55am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: America Movil, Comerica, Johnson & Johnson, Monster Beverage and More
Friday's top analyst upgrades and downgrades included America Movil, Comerica, Johnson & Johnson, Monster Beverage and Shoals Technologies.
7:10am ET
Investing
8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should be looking…
8:54am ET
Investing
Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
11:44am ET
Investing
Earnings Previews: Ericsson, Johnson & Johnson, Lockheed Martin
A Dow pharmaceutical company, the largest U.S. defense contractor and a Stockholm-based network equipment giant will report quarterly results on Tuesday morning.
7:35am ET
Investing
Before the Bell: Gold Nears All-Time High, Short Seller Goes After AI, and Trouble in Crypto Paradise
Gold prices are threatening to post a new all-time high, a short seller is challenging accounting practices at an AI firm, and J&J has agreed to pay $8.9 billion to settle claims…
7:14am ET
Investing
Sell the Rally Before Q1 Earnings: 7 Safe Warren Buffett Dividend Stocks to Grab Now
For investors looking for safe-haven stocks, these seven Warren Buffett stock picks are quality names with among the largest dividends, and they may provide some shelter from the coming economic storm.
7:02am ET
Investing
Warren Buffett Owns Millions of Shares of These 3 Top ‘Strong Buy’ Dividend Aristocrats
These three Dividend Aristocrats have been longtime members of Warren Buffett's portfolio. Because they generate dependable, growing dividends, you can bet that they will remain Berkshire Hathaway holdings for years to come.
8:46am ET
Investing
Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More
Thursday's top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta, Monster Beverage, Rivian Automotive, Spirit AeroSystems, Workday and XP.
11:38am ET
Investing
Earnings Previews: Johnson & Johnson, 3M, Verizon
Three Dow stocks are set to post quarterly results before U.S. markets open on Tuesday. Two of the three are among this year's Dogs of the Dow.